HUYA Bioscience International expands senior management team

Recruits Dmitri Kharkevitch as Vice President for Clinical Development

Biopharmaceutical firm HUYA Bioscience has added Dmitri Kharkevitch to its senior management team as Vice President, Clinical Development Oncology. He will support the company's expansion of its clinical development programmes for its lead anti-cancer drug HBI-8000.

Kharkevitch has more than 30 years of experience in oncology which includes 15 years in leadership positions within pharma and biotech covering clinical and medical affairs at Roche, Pfizer, Bristol-Myers Squibb, Vical, Antigenics and MD Anderson Cancer Centre in Houston, TX, US.

He brings experience in all phases of drug development for haematology and solid tumours to the company.

You may also like

Research & Development

HUYA Bioscience and Zhongshan Technology Park form alliance

To accelerate discovery and development of biopharmaceuticals in China
Marketing

Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation

The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Regulatory

Tivdak receives US FDA approval for treating recurrent cervical cancer

The full approval of tisotumab vedotin will offer a treatment for patients with metastatic or recurrent cervical cancer exhibiting disease progression on or after chemotherapy
Manufacturing

Marchesini Group at Achema 2024: celebrating 50 years of innovation

At G3, Hall 3.1, the Marchesini Group will exhibit pharmaceutical manufacturing machines, packaging solutions and digital tools to enhance manufacturing processes
Distribution

Tower Cold Chain’ industry-first shipping container design

The pyramidal solution allows pharmaceuticals to be shipped at a consistent temperature between -60°C to above +20°C for up to 96 hours
Pharmaceutical

High-precision temperature control solutions for the pharmaceutical industry and biotechnology, available in the UK from Labtex

Huber offers a world-renowned range of temperature control systems and associated accessories for the Pharmaceutical Industry and Biotechnology
Sustainability

Building strong foundations for a resilient and planet-friendly future

Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
Subscribe now